Changes in self-concept and body image during alopecia induced cancer chemotherapy
- PMID: 9069615
- DOI: 10.1007/BF01262572
Changes in self-concept and body image during alopecia induced cancer chemotherapy
Abstract
Alopecia as a result of cancer chemotherapy has been reported to cause changes to the self-concept and body image. In a prospective longitudinal study, self-concept and body image were analysed in 29 patients after histological confirmation of gynaecological malignancy, mainly ovarian cancer, who were assigned to receive a complete-alopecia-inducing PEC combination chemotherapy (cisplatin 50 mg/m2, epirubicin 60 mg/m2, and cyclophosphamide 500 mg/m2 in 1 day every 28 days). The analysis was performed before the commencement of treatment and repeated when alopoecia was complete and after completion of therapy when patients had already experienced regrowth of hair, using the Frankfurt self-concept scales (FSKN) and Frankfurt body concept scales (FKKS). Significant differences were observed in the various evaluation scales FSAP (general ability to solve problems), FSSW (general self-esteem), SGKB (state of health), and SKEF (physical fitness). For all scales the results worsened during chemotherapy but did not return to normal or improve when patients experienced regrowth of hair. It was found that 73.3% of the patients did not feel as self-confident as before treatment and that for 46.6% alopecia was the most traumatic side effect of chemotherapy. Since there is no chemotherapeutic regimen or any other effective treatment that can prevent alopecia, either of the following conclusions can be drawn: the observed differences may not be related exclusively to alopecia, but also associated with coping processes initiated by chemotherapy and perhaps enhanced by alopecia; or the changes persist even after the discontinuation of chemotherapy. Regrowth of hair and other adaptive processes do not normalize or improve the impaired body image and self-concept.
Similar articles
-
A randomized clinical trial of a videotape intervention for women with chemotherapy-induced alopecia: a gynecologic oncology group study.Oncol Nurs Forum. 2006 Nov 3;33(2):305-11. doi: 10.1188/06.ONF.305-311. Oncol Nurs Forum. 2006. PMID: 16518446 Clinical Trial.
-
The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer.Eur J Cancer Care (Engl). 2013 Jul;22(4):503-12. doi: 10.1111/ecc.12056. Epub 2013 Mar 26. Eur J Cancer Care (Engl). 2013. PMID: 23528018
-
A comparison of men and women's experiences of chemotherapy-induced alopecia.Eur J Oncol Nurs. 2013 Jun;17(3):255-60. doi: 10.1016/j.ejon.2012.06.003. Epub 2012 Aug 14. Eur J Oncol Nurs. 2013. PMID: 22901547
-
Embodying identity in chemotherapy-induced alopecia.Perspect Psychiatr Care. 2012 Apr;48(2):116-21. doi: 10.1111/j.1744-6163.2011.00314.x. Epub 2011 Jul 5. Perspect Psychiatr Care. 2012. PMID: 22458725 Review.
-
Hair loss: alopecia fears and realities for survivors of breast cancer-a narrative review.Ann Palliat Med. 2024 Sep;13(5):1235-1245. doi: 10.21037/apm-24-69. Epub 2024 Aug 5. Ann Palliat Med. 2024. PMID: 39129521 Review.
Cited by
-
Comparison of the Efficacy of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Improving Survival and Quality of Life in the Advanced Ovarian Cancer Patient Population: A Systematic Review and Meta-Analysis of Randomized Control Trials.Cureus. 2023 Dec 23;15(12):e51011. doi: 10.7759/cureus.51011. eCollection 2023 Dec. Cureus. 2023. PMID: 38264391 Free PMC article. Review.
-
Shorter post-infusion cooling times at least as effective as longer cooling times - An observational study of taxane- and anthracycline-based chemotherapies in the Dutch Scalp Cooling Registry.Support Care Cancer. 2025 May 28;33(6):503. doi: 10.1007/s00520-025-09526-2. Support Care Cancer. 2025. PMID: 40434428
-
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.JAMA Dermatol. 2020 Sep 1;156(9):963-972. doi: 10.1001/jamadermatol.2020.2127. JAMA Dermatol. 2020. PMID: 32756880 Free PMC article.
-
Sexual Dysfunction in Alopecia Areata: A Systematic Review.J Clin Med. 2025 Apr 10;14(8):2602. doi: 10.3390/jcm14082602. J Clin Med. 2025. PMID: 40283432 Free PMC article. Review.
-
A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.Breast Cancer Res. 2013;15(5):R81. doi: 10.1186/bcr3475. Breast Cancer Res. 2013. PMID: 24025145 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical